New York State Common Retirement Fund’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,151
Closed -$20.9K – 3221
2025
Q1
$20.9K Hold
1,151
– – ﹤0.01% 2969
2024
Q4
$42.7K Hold
1,151
– – ﹤0.01% 2891
2024
Q3
$36.8K Hold
1,151
– – ﹤0.01% 2945
2024
Q2
$94.5K Buy
1,151
+428
+59% +$46.3K ﹤0.01% 2892
2024
Q1
$105K Sell
723
-17
-2% -$1.44K ﹤0.01% 2717
2023
Q4
$68.1K Sell
740
-610
-45% -$62K ﹤0.01% 2899
2023
Q3
$223K Buy
1,350
+1,157
+599% +$150K ﹤0.01% 2380
2023
Q2
$12.2K Sell
193
-5
-3% -$303 ﹤0.01% 3258
2023
Q1
$6.71K Sell
198
-2,107
-91% -$110K ﹤0.01% 3194
2022
Q4
$133K Sell
2,305
-4
-0.2% -$247 ﹤0.01% 2876
2022
Q3
$217K Sell
2,309
-522
-18% -$74.3K ﹤0.01% 2742
2022
Q2
$632K Buy
2,831
+146
+5% +$48.9K ﹤0.01% 2244
2022
Q1
$1.48M Buy
2,685
+54
+2% +$32.6K ﹤0.01% 1908
2021
Q4
$1.74M Sell
2,631
-196
-7% -$150K ﹤0.01% 1847
2021
Q3
$2.37M Sell
2,827
-526
-16% -$534K ﹤0.01% 1674
2021
Q2
$4.26M Sell
3,353
-3,931
-54% -$4.44M ﹤0.01% 1412
2021
Q1
$7.99M Sell
7,284
-496
-6% -$655K 0.01% 1072
2020
Q4
$11.1M Sell
7,780
-141
-2% -$150K 0.01% 884
2020
Q3
$5.59M Sell
7,921
-355
-4% -$258K 0.01% 1124
2020
Q2
$5.79M Buy
8,276
+1,026
+14% +$592K 0.01% 1103
2020
Q1
$2.54M Sell
7,250
-2,080
-22% -$1.47M ﹤0.01% 1319
2019
Q4
$5.87M Sell
9,330
-6,540
-41% -$3.2M 0.01% 1180
2019
Q3
$5.32M Buy
15,870
+419
+3% +$134K 0.01% 1213
2019
Q2
$4.01M Buy
15,451
+14,551
+1,617% +$2.91M 0.01% 1346
2019
Q1
$149K Hold
900
– – ﹤0.01% 2839
2018
Q4
$97K Buy
900
+400
+80% +$67.4K ﹤0.01% 2971
2018
Q3
$125K Hold
500
– – ﹤0.01% 3000
2018
Q2
$109K Buy
+500
New +$92.5K ﹤0.01% 3069

Other funds holding CDLX

New York State Common Retirement Fund's CDLX Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,151 shares — an estimated $20.9K sold.

New York State Common Retirement Fund first reported a position in CDLX in Q2 2018 and held it in 28 quarters. The position peaked at $11.1M in Q4 2020. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,151 Cardlytics shares in Q2 2025, an estimated $20.9K.
  • New York State Common Retirement Fund first reported a position in Cardlytics in Q2 2018 and held it in 28 quarters.
  • New York State Common Retirement Fund's Cardlytics position peaked at $11.1M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.